Share-based payments - Summary of options outstanding (Details) OPTION in Millions |
12 Months Ended | |||
|---|---|---|---|---|
|
Mar. 31, 2026
OPTION
£ / shares
|
Mar. 31, 2025
OPTION
£ / shares
|
Mar. 31, 2024
OPTION
£ / shares
|
Mar. 31, 2023
OPTION
£ / shares
|
|
| Summary of options outstanding and exercisable | ||||
| Outstanding shares | OPTION | 59 | 65 | 70 | 62 |
| Weighted average exercise price | £ 0.61 | £ 0.62 | £ 0.66 | £ 0.87 |
| Weighted average remaining contractual life | 14 months | 23 months | ||
| Minimum | ||||
| Summary of options outstanding and exercisable | ||||
| Weighted average exercise price | £ 0.58 | |||
| Maximum | ||||
| Summary of options outstanding and exercisable | ||||
| Weighted average exercise price | £ 1.28 | |||
| X | ||||||||||
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. No definition available.
|
| X | ||||||||||
- Definition The number of share options outstanding in a share-based payment arrangement. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|